TAK

Takeda Pharmaceutical Company Limited - ADR

17.89

USD

TAK Earnings Reports

Positive Surprise Ratio

TAK beat 27 of 39 last estimates.

69%

Next Report

Date of Next Report

May 13, 2026

Estimate for Q4 26 (Revenue/ EPS)

$1.10T

-$13.13

Implied change from Q3 26 (Revenue/ EPS)

-7.64%

-120.00%

Implied change from Q4 25 (Revenue/ EPS)

+4.48%

-79.91%

Takeda Pharmaceutical Company Limited - ADR earnings per share and revenue

On Jan 30, 2026, TAK reported earnings of 65.64 USD per share (EPS) for Q3 26, beating the estimate of 34.44 USD, resulting in a 90.61% surprise. Revenue reached 1.19 trillion, compared to an expected 1.19 trillion, with a 0.21% difference. The market reacted with a +0.35% price change (close before vs. close after earnings).

Looking ahead to Q4 26, 5 analysts forecast an EPS of -13.13 USD, with revenue projected to reach 1.10 trillion USD, implying an decrease of -120.00% EPS, and decrease of -7.64% in Revenue from the last quarter.

FAQ

What were Takeda Pharmaceutical Company Limited - ADR's earnings and revenue for the latest quarter Q3 2026?

For Q3 2026, Takeda Pharmaceutical Company Limited - ADR reported EPS of $65.64, beating estimates by 90.61%, and revenue of $1.19T, 0.21% above expectations.

How did the market react to Takeda Pharmaceutical Company Limited - ADR's Q3 2026 earnings?

The stock price moved up 0.35%, changed from $17.17 before the earnings release to $17.23 the day after.

When is Takeda Pharmaceutical Company Limited - ADR expected to report next?

The next earning report is scheduled for May 13, 2026.

What are the forecasts for Takeda Pharmaceutical Company Limited - ADR's next earnings report?

Based on 5 analysts, Takeda Pharmaceutical Company Limited - ADR is expected to report EPS of -$13.13 and revenue of $1.10T for Q4 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.